12 August 2022 : Original article
Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival
Ion Mărunţelu12ABCDEF, Claudiu Eduard Nistor
2CEF*, Bogdan Mihai Cristea2CE, Corina Andreea Rotarescu12BCD, Andreea Mirela Caragea2B, Maria Tizu2B, Ileana Constantinescu12AD
DOI: 10.12659/AOT.937267
Ann Transplant 2022; 27:e937267
Table 2 Prevalence of posttransplant de novo HLA antibodies.
| HLA antibodies | Patients n (%) |
|---|---|
| Total | 320 (100%) |
| Not detected | 272 (85%) |
| Detected | 48 (15%) |
| Class I | |
| Not detected | 298 (93.13%) |
| Detected | 22 (6.87%) |
| Class II | |
| Not detected | 283 (86.93%) |
| Detected | 37 (13.07%) |
| HLA – human leukocyte antigen. | |